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Highlights 
1. This is the largest and longest studied cohort of workers exposed to PCBs for whom 
serum values are available 
2. We present PCB half-life estimates using sera from four time points 
3. PCB half-life estimates are for two commercial PCB mixtures (Aroclor 1254 and 1242)  
4. Two serum PCB elimination rates were discovered (rapid and then slow) 
5. Gender differences were observed only for Aroclor 1242 in earlier years.   
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 5 
Abstract 6 
 7 
Polychlorinated biphenyls (PCBs) are carcinogenic. Estimating PCB half-life in the body based 8 
on levels in sera from exposed workers is complicated by the fact that occupational exposure to 9 
PCBs was to commercial PCB products (such as Aroclors 1242 and 1254) comprised of varying 10 
mixtures of PCB congeners.  Half-lives were estimated using sera donated by 191 capacitor 11 
manufacturing plant workers in 1976 during PCB use (1946-1977), and post-exposure (1979, 12 
1983, and 1988).  Our aims were to: (1) determine the role of covariates such as gender on the 13 
half-life estimates, and (2) compare our results with other published half-life estimates based on 14 
exposed workers.  All serum PCB levels were adjusted for PCB background levels. A linear 15 
spline model with a single knot was used to estimate two separate linear equations for the first 16 
two serum draws (Equation A) and the latter two (Equation B).  Equation A gave half-life 17 
estimates of 1.74 years and 6.01 years for Aroclor 1242 and Aroclor 1254, respectively.  18 
Estimates were 21.83 years for Aroclor 1242 and 133.33 years for Aroclor 1254 using Equation 19 
B.  High initial body burden was associated with rapid PCB elimination in workers at or shortly 20 
after the time they were occupationally exposed and slowed down considerably when the dose 21 
reached background PCB levels.  These concentration-dependent half-life estimates had a 22 
transition-point of 138.57 and 34.78 ppb for Aroclor 1242 and 1254, respectively. This result 23 
will help in understanding the toxicological and epidemiological impact of exposure to PCBs in 24 
humans. 25 
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1.0 Introduction 26 
Many electrical equipment manufacturing workers in the United States were exposed to 27 
polychlorinated biphenyls (PCBs) before their use was banned in 1977.  The National Institute 28 
for Occupational Safety and Health (NIOSH) is conducting epidemiologic studies of the possible 29 
health consequences of occupational exposure to PCBs at three capacitor manufacturing plants 30 
(Prince et al., 2006; Rocheleau et al 2011; Ruder et al., 2006; Silver et al., 2009; Steenland et al., 31 
2006), using job-exposure matrices as a surrogate for PCB body burden.   32 
 33 
The PCB body burden (dose levels) over time depends upon toxicokinetics, which includes 34 
elimination half-lives (Shirai and Kissel, 1996).  Intrinsic human elimination half-lives for PCBs 35 
were 10-15 years in a recent study (Ritter et al 2011), derived from cross-sectional biomonitoring 36 
data. In humans with occupational exposure to PCBs, several studies have provided estimates for 37 
PCB half-life varying from < 1 year to 71 years (Steele et al., 1986; Phillips et al., 1989; Taylor 38 
and Lawrence, 1992; Wolff et al., 1992, Seegal et al., 2011).  These previous half-life estimates 39 
were usually based on only two measurements. The objectives of the current effort were to 40 
develop estimates of the half-lives of commercial PCB mixtures Aroclor 1242 and Aroclor 1254 41 
using all available sera from a select group of workers from one of the three plants, to consider 42 
the role of high initial body burden and gender on the half-life estimates, and to compare the 43 
results with other published half-life estimates based on occupational exposure.  The estimates 44 
were adjusted for PCB background levels (Hopf et al 2009). This is the only study that 45 
incorporates four PCB blood measurements over time, allowing us to explore PCB elimination 46 
rates.  47 
 48 
 49 
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2.0 Background 50 
Shirai and Kissel (1996) reviewed fourteen studies of humans with occupational, accidental, or 51 
experimental exposure to PCBs and concluded that very short (i.e., < 1 year) and very long (i.e, 52 
> 10 years) half-lives were probably unlikely.  The exponential decay model, assuming first-53 
order kinetics, is given by 54 
X(t) = X(t0) e –λ(t-t0) 55 
where X(t) is the concentration in the compartment at time t, X(t0) is the unknown initial 56 
concentration at time t0, and λ is the elimination constant which has units of time-1.  The half-life, 57 
t1/2, is defined as the length of time after which the initial concentration of the chemical is 58 
reduced by half, and is equal to the natural logarithm of 2 divided by the elimination constant, or 59 
t1/2 = ln(2) / λ (Cassarett and Doull, 1986). 60 
 61 
In a controlled pharmacokinetic study, the initial concentration of a chemical in a compartment is 62 
known and subsequent concentrations are measured at specific time points.  In occupational 63 
studies, the initial concentration of a chemical in a compartment after first exposure is usually 64 
unknown.  Also, exposure typically is chronic, not acute, occurring at different rates over 65 
different periods of time.  However, measurements taken after exposure is known to have ceased 66 
can be used to estimate the half-life for elimination of the chemical from the sera compartment.   67 
 68 
Estimating the half-life of PCBs in the body using sera from exposed workers is complicated; 69 
occupational exposure to PCBs was generally to commercial PCB products comprised of varying 70 
mixtures of some of the 209 PCB congeners.  Different methods exist for quantifying the level of 71 
PCBs in sera (Lawton et al., 1985a).  Ideally, congener-specific serum PCB levels would be 72 
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measured.  However, in the past, results were typically either quantified using an “Aroclor 73 
standard” by summing the heights of selected peaks on the gas chromatogram (GC) which 74 
correlated with hallmark peaks in a specific Aroclor, or quantified as lower- or higher-75 
chlorinated PCBs (LPCBs or HPCBs) based on the sum of the GC peaks that occurred before or 76 
after the retention time of p,p’-dichlorodiphenyldichloroethylene (DDE), universally detected in 77 
sera from people in the industrialized world.  The two methods of quantifying PCBs in sera are 78 
related, with 93% of Aroclor 1242 being LPCBs and 96% of Aroclor 1260 being HPCBs 79 
(Lawton et al., 1985b).  The range of chlorination of the Aroclors in sera was determined to be 80 
Aroclor 1016: 2-5 chlorines, Aroclor 1242: 2-6 chlorines, Aroclor 1254: 4-7 chlorines, and 81 
Aroclor 1260: 4-8 chlorines (Lawton et al., 1985b). 82 
 83 
In addition to degree of chlorination, several other factors are considered to be related to the half-84 
life of PCBs in humans.  Wolff et al. (1992) found PCBs in serum from workers (N=60) in jobs 85 
with high and direct PCB exposure had shorter half-lives for lower chlorinated PCBs than PCBs 86 
in serum from workers (N=105) in jobs with low and indirect PCB exposure (4.8 versus 17 87 
years, respectively).  A follow-up study of some of these workers (N=45) 28 years later (Seegal 88 
et al., 2011), showed somewhat longer half-lives than Wolff et al. (1992) had, but showed the 89 
same trend with respect to high initial PCB body burden: half-life estimates for lower chlorinated 90 
PCBs were 13.5 and 7.3 years and for higher chlorinated PCBs were 32.6 and 12 years for low 91 
and high exposed workers, respectively.  Factors complicating the estimation of PCB half-life 92 
include percent body fat, laboratory measurement error (Caudill et al., 1992), the time interval 93 
between measurements (Caudill et al., 1992), and continuing low-level exposure to PCBs (Shirai 94 
and Kissel, 1996), such as background levels of exposure (Michalek et al., 1998). 95 
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 96 
Different statistical methods have been proposed for determining the half-life of a substance in 97 
humans from an exposed population.  The choice of method often depends on the number of 98 
participants and the number of measurements available for each participant over time.  Steele et 99 
al. (1986) used linear regression to estimate the half-lives of PCBs in the body using sera 100 
quantified as Aroclors 1242 and 1260.  Five capacitor manufacturing workers at one of the 101 
NIOSH cohort plants, selected because of their high probability of PCB exposure, provided sera 102 
at two draws separated by 84 months. The analysis produced half-life estimates of 2.0 years for 103 
Aroclor 1242, 27.6 years for Aroclor 1260, and 11.5 years for total serum PCBs.  The median 104 
technique was developed by Phillips et al. (1989) to estimate the half-lives of Aroclors 1242 and 105 
1254 for 60 former capacitor manufacturing workers (at the same NIOSH cohort plant) with two 106 
serum draws separated by 100 months.  Phillips et al. reported half-life estimates of 2.6 years for 107 
Aroclor 1242 and 4.8 years for Aroclor 1254.  In addition, they observed a decreasing trend in 108 
half-life based on initial concentration of PCBs in 1977, although Shirai and Kissel (1996) 109 
showed that this was likely due to confounding by continuing exposure to PCBs.  Table 1 gives 110 
an overview of previous half-life estimates from US occupational exposed populations and type 111 
of statistical methods used to derive these half-lives.   112 
 113 
Lawton et al. (1985b) initiated a research study in 1976 to study the possible health effects of 114 
PCB exposure in workers at another capacitor manufacturing plant (also in the NIOSH cohort) 115 
with two facilities in upstate New York.  Aroclor 1254 was used at this plant from 1946-1954, 116 
Aroclor 1242 from 1954-1971, and Aroclor 1016 from 1971-1977 (Lawton et al., 1985b).  In 117 
1976, 194 employees, selected because their jobs “required direct contact with PCB in zones of 118 
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high air concentration, were in the immediate periphery of the high exposure zone, or had high 119 
but intermittent exposure”, underwent examinations that included the collection of blood sera 120 
from most (n=191).  This first examination was approximately one year prior to the termination 121 
of PCB use at the plant.  Serum draws were repeated in 1979, 1983, and 1988 for subsets of the 122 
191 participants.  Taylor et al. (1992) used measured serum PCB levels from 148 of the workers 123 
who provided sera in both 1979 and 1983 to produce half-life estimates of 1.8 years (95% 124 
confidence interval (CI) =1.7 – 1.9) for Aroclor 1242, 3.3 years (95% CI=3.0 – 3.8) for Aroclor 125 
1254, and 4.1 years (95% CI=3.6 – 4.7) for Aroclor 1260.   126 
 127 
3.0 Materials and Methods 128 
The basis for the Aroclor half-life estimates were the Aroclor 1242, 1254, and 1260 serum levels 129 
calculated by Lawton et al. (1985).  According to study plant records, the use of PCBs in the two 130 
facilities ended 30 June 1977.  Time intervals from last exposure were measured from that date.  131 
Specific dates of the serum draws were not known, but estimated as 15 March 1976, 15 132 
November 1979, 15 November 1983, and 1 November 1988 since it is known that PCBs were 133 
“still in use during the first 1.3 years after the first examination” (Brown et al., 1989); the second 134 
serum draw was in November 1979 (Brown et al., 1984);  the third serum draw was 48 months 135 
after the second (Taylor et al., 1992);  and the fourth serum draw occurred in 1988.   136 
 137 
A majority of the 191 participants in the Lawton study provided sera at four time points 138 
(122/194, 63%).  Thirty-five participants provided sera at three time points, 19 at two, 15 at one, 139 
and three did not provide sera at any of the time points.  Therefore, our statistical analysis was 140 
performed using results of 191 workers. PCB serum levels were quantified for 185 participants 141 
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in 1976, 173 in 1979, 150 in 1983, and 138 in 1989.  Most participants were male (152/194, 142 
78%).   143 
 144 
The methods for quantifying PCB levels (packed column GC with electron capture detector) in 145 
the serum have been described (Lawton et al., 1985a).  Aroclor standards were used to calculate 146 
PCB levels in terms of “Aroclor 1242” and “Aroclor 1254”.  Serum PCB levels were quantified 147 
by summing peak heights with relative retention times of 37, 70, and 84 as Aroclor 1242 and 148 
with relative retention times of 125, 146, 160, and 184, as described in Lawton et al (1985a) as 149 
Aroclor 1254 (Brown et al., 1989).  (Peak 184 differed from the relative retention time of 174 150 
described in the Webb-McCall method (Webb and McCall, 1973). 151 
 152 
Although PCB exposure was ongoing at the time of the first serum measurement, it might be 153 
possible to use data from the 1976 serum draw to estimate the half-life for Aroclor 1254 (Brown 154 
et al., 1989) since Aroclor 1254 was only used from 1946-1954 at the study plant (Lawton et al., 155 
1985b).  Other than gender, information on factors known to affect half-life such as age and 156 
percent body fat was unavailable.  All statistical analyses were performed using SAS 9 Software 157 
(SAS Institute Inc., Cary, NC). 158 
 159 
Background PCB levels might contribute to the length of the half-life estimates; therefore an 160 
adjustment for PCB background levels for the years 1976, 1979, 1983, and 1988 was needed.  161 
No national statistically based cross-sectional data concerning historical serum PCB levels exist 162 
for the U.S. population by year. Therefore, we estimated the background PCB serum levels for 163 
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these four time points based on the scientific literature (Hopf et al., 2009).  The background PCB 164 
levels were estimated to follow negative exponential "die away" curves;  165 
• for Aroclor 1242;  corr_pcb = pcb - 4.18*exp(-0.088*(year-1977)); 166 
• for Aroclor 1254; corr_pcb = pcb - 8.5788*exp(-0.0569*(year-1977)); 167 
where corr_pcb represents the serum PCB levels (ppb) corrected for background, and pcb is the 168 
uncorrected values. Adjustments for PCBs background serum levels were performed by 169 
subtracting the estimated background population serum PCB concentrations from the measured 170 
serum PCB concentrations prior to log transformation. 171 
 172 
Quantile-quantile plots of natural-log-transformed serum PCB levels (ln(PCB)) versus standard 173 
normal quantiles indicated that the data were lognormally distributed (not shown).  Figures 1 and 174 
2 depict the individual profiles of the log-transformed serum PCB levels over time, for Aroclors 175 
1242 and 1254, respectively.  Vertical reference lines indicate the times of the serum draws 176 
relative to the end of PCB use, and average trend lines were fit using a smoothing routine for 177 
females and males.  The quadratic term for time was statistically significant for fitting a linear 178 
model for all years, indicating that the assumptions of a first-order kinetic model were violated.  179 
From the graphs it was apparent that the decrease in earlier years was faster than in later years. 180 
This bi-phasic elimination was consistent with elimination patterns from high initial body burden 181 
of other chlorinated persistent chemicals such as TCDD (Aylward et al. 2005).  Therefore, a 182 
linear spline model with a single knot (Keele 2008; Altshuler 1981) approach was used to 183 
demonstrate that there were two slopes underlying the die-away curve. This model fit the data 184 
well; a linear equation was fitted for the 1976 and 1979 data (Equation A), and a second linear 185 
equation was used to fit the 1983 and 1988 data (Equation B) using PROC MIXED. The equality 186 
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of the slopes estimated over the two time periods was tested by analyzing all the data in a single 187 
model which included the interaction between periods with slope.  The dependent variables were 188 
the natural log transformed PCB Aroclors ln(PCB). 189 
 190 
The point (transition point) where Equation A and Equation B intersected was estimated by 191 
determining the year during which the two regression equations for equations A and B provided 192 
the same estimate for PCB concentrations. Other parameters besides background PCB levels 193 
affecting elimination such as additional elimination mechanisms (PCB fecal elimination of 194 
unchanged compound through lipid partitioning into the large intestine) were unknown and could 195 
not be included in the model; hence our model estimates half-life elimination rates based on 196 
PCBs (not metabolites) circulating in the blood. The transition point indicating a possible change 197 
in elimination rate from rapid to slow was calculated.  198 
 199 
4.0 Results 200 
Aroclor 1242 quantified measurements increased in five participants from 1976 to 1979, in four 201 
participants from 1979 to 1983, and in 32 participants from 1983 to 1988.  Likewise, Aroclor 202 
1254 quantified measurements increased in 49 participants from 1976 to 1979, in 16 participants 203 
from 1979 to 1983, and in 50 participants from 1983 to 1988.   204 
 205 
Detailed work histories, available for 192 of the 194 participants, described 2,684 years of 206 
employment at the study plant during the era of PCB exposure (January 1, 1946 – June 30, 207 
1977).  The median year first employed was 1965 (range 1946 – 1974) and the median duration 208 
of employment was 11 years (range 1 – 30 years). 209 
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 210 
Summary statistics for the measured serum PCB levels, quantified as Aroclors 1242 and 1254 in 211 
parts per billion (ppb) with and without corrections for background serum PCB levels, are 212 
provided in Table 2.  Measured serum PCB levels were highly variable within a given year.  The 213 
difference between corrected and uncorrected serum PCB levels was minimal in earlier years due 214 
to the high serum PCB levels (e.g. 1976: GM was 1,521 ppb) compared to the value used to 215 
adjust for background levels. 216 
 217 
The year Equation A and Equation B intersected (transition point) for Aroclor 1242 was 1980 218 
and for Aroclor 1254, 1982. We did not find a statistical significant difference in half-life 219 
estimates between genders for Aroclor 1254. This was also true for Aroclor 1242 in later years 220 
(Equation B).  However, the Aroclor 1242 half-life estimate for equation A (1976-1979) was 221 
significantly longer in females (half-life of 2.15 years, 95% confidence interval [C.I.] 1.7 – 2.9 222 
years) as compared to males (1.7 years, 95% C.I. 1.4 – 2.2 years, t=2.21, p<0.03). 223 
 224 
The transition point concentration for Aroclor 1242 and 1254 were 138.57 and 34.78 ppb, 225 
respectively. The elimination kinetics of PCBs were concentration dependent with faster rates 226 
observed at higher concentrations (>138.57 ppb for Aroclor 1242 and >34.78 ppb for Aroclor 227 
1254 ppb) and the transition to slower rates occurring below this concentration.  228 
 229 
Results of the repeated measures regression models and subsequent half-life estimates are 230 
provided in Table 3.  In the linear spline model with a single knot, the first slope using the first 231 
two serum draws (Equation A) produced an estimated half-life of 1.74 years for Aroclor 1242 232 
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(95% CI =  1.60 – 1.89 years) and 6.01 years for Aroclor 1254 (95% CI = 4.53 – 8.93 years).  233 
Using the last two serum draws (Equation B) to model the second slope produced an estimated 234 
half-life of 21.83 years for Aroclor 1242 (95% CI =  16.92 – 30.76 years) and 133.33 years for 235 
Aroclor 1254 (95% CI = 52.88 - ∞ years).  The slopes estimated for the two time periods were 236 
significantly different (p<0.0001).   237 
 238 
We compared the geometric means (cGM) of predicted values of Aroclor 1242 with actual cGM 239 
for 1976 (predicted 1503: actual 1528), 1979 (predicted 274: actual 280), 1983 (predicted 115: 240 
actual 125), and 1988 (predicted 91: actual 92); and for Aroclor 1254: 1976 (predicted 78: actual 241 
85), 1979 (predicted 48: actual 55); 1983 (predicted 28: actual 35), and 1988 (predicted 27: 242 
actual 32).   243 
 244 
5.0 Discussion 245 
Estimates of the half-lives of PCBs were based on sera drawn from the same individuals at up to 246 
four time points.  The half-life, defined as the change in concentration in the body over time is 247 
the net result of elimination from the body, changes in the body composition, and intake from the 248 
environment. Factors affecting elimination are age, smoking, initial body burden, body fat, and 249 
gender (Milbrath et al 2009).  Although the gender of each participant was known, age and body 250 
mass index data were not available; therefore, it was not possible to adjust for covariates other 251 
than gender.   252 
 253 
Half-life estimates for sera from female participants were generally longer than half-life 254 
estimates for sera from male participants, although the gender difference was only statistically 255 
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significant for Aroclor 1242 in the earlier years (equation A).  This gender difference in half-life 256 
estimates was also seen in Seegal et al., (2011) not only in lower but also higher chlorinated 257 
PCBs.  PCBs are known to be stored in adipose tissue, therefore half-life estimates are 258 
potentially confounded by percent body fat in addition to the rate of PCB migration to the blood 259 
(Brown, 1994) or hormonal differences (Kang et al,. 2008; Cerna et al., 2008).  No clear 260 
explanations for this gender-related difference exist, and further investigation is needed. 261 
 262 
High initial PCB body-burden showed a concentration-dependent biphasic elimination rate, 263 
which has been identified in related compounds such as 2,3,7,8-tetrachloro-p-dibenzo-dioxin 264 
(TCDD) and penta-chlorodibenzofuran (PeCDF) in cases of acute poisoning (Abraham et al 265 
2002), Seveso incident (Aylward et al 2005; Michalek et al 2002) in children (Kerger et al 2006), 266 
Yusho and Yu-Cheng rice oil poisoning (Leung et al 2007; Ryan et al 1993), but has until now 267 
not been reported in workers with chronic high exposures. This non-linear behavior might be due 268 
to possible enzyme induction similarly to that seen in TCDD and pentaCDF, as enzyme 269 
induction has been observed previously in animals exposed to PCBs (Emond et al, 2005). 270 
 271 
Not adjusting for background PCB levels did not have an impact on equation A (half-lives not 272 
corrected for background levels: Aroclor 1242: 1.75 years and Aroclor 1254: 6.8 years).  The 273 
half-life estimates for uncorrected serum PCB levels using equation B were shortened; giving 274 
Aroclor 1242 an half-life of 20.4 years and statistically significantly shortened half-life for 275 
Aroclor 1254 of 69.5 years. Since most of these individuals continued to live in the vicinity of 276 
the plant they would have an ongoing environmental exposure as would eating contaminated fish 277 
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in the 1980s. Accounting for background PCB levels will give a more realistic estimate of the 278 
half-life.  279 
 280 
Serum levels were reduced by approximately 90% and 50% between the first and third serum 281 
draws for Aroclors 1242 and 1254, respectively, but increased between the third and fourth 282 
serum draws for 23% and 36% of the participants.  By the fourth serum draw, serum PCB levels 283 
had fallen to much lower levels and were possibly approaching the levels of those in the general 284 
population who have somewhat elevated environmental exposures.  The reasons for the increases 285 
in serum PCB levels between consecutive serum draws seen in some workers are not known.  286 
Possible explanations are de-chlorination of congeners to lower chlorinated PCB; where 287 
particular congeners would be quantified as Aroclor 1254 in earlier serum draws, and as Aroclor 288 
1242 in later serum draws.  Continued occupational exposures were possible for those workers 289 
who dismantled the plant, and as mentioned above living in the vicinity could give higher 290 
environmental exposures.  Other factors that could lead to increases in PCBs in these workers are 291 
laboratory measurement error, increased release of PCBs into the blood from body fat storage, or 292 
a combination of factors. These factors could lead to unrealistic long half-life estimates.  293 
 294 
Dioxin-like (DL) PCBs (PCB77, PCB 81, PCB 126, PCB 169, PCB 105, PCB 114, PCB 118, 295 
PCB 123, PCB 156, PCB 157, PCB 167, PCB 89) are tetra-, penta-, and hexa-chlorinated 296 
congeners. A complete PCB congener distribution of Aroclor mixtures has been published 297 
(Frame et al 1996), and the weight% of DL-PCB congeners for Aroclor 1016, Aroclor 1242, and 298 
Aroclor 1254 were 0%, 1.95%, and 23.58%, respectively. Therefore workers in the early time 299 
period exposed to Aroclor 1254 (before the 1960s) had higher DL-PCB exposures compared to 300 
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workers who were only exposed to Aroclor 1242 (~1960-1970) and Aroclor 1016 (in the 1970s) 301 
used in later time periods. DL-PCBs in workers’ blood samples can be estimated from Seegal et 302 
al 2011;  they re-analyzed stored blood samples previously determined as lower (LPCBs; peaks 303 
eluding before DDE in the chromatogram) and higher (HPCBs; peaks eluding after DDE in the 304 
chromatogram) PCBs, and found four DL-PCBs congeners (118, 105, 167, 156); all present in 305 
peaks quantified as HPCBs.  306 
 307 
Shirai and Kessel (1996) reasoned that half-lives longer than 10 years were probably the result of 308 
confounding by additional exposure.  Wolff et al. (1992), on the other hand, observed long half-309 
lives which they attributed to the presence of congeners with relatively longer half-lives in the 310 
sera compared to the distribution of congeners in the Aroclor mixtures.  The explanation we can 311 
offer is that elimination of PCB congeners with shorter half-lives (generally, lower chlorinated 312 
biphenyls) from high initial PCB serum levels is estimated with Equation A, while Equation B is 313 
an estimate of the elimination of PCB congeners with long half-life as described by Wolff et al 314 
(1992) with continuous exposure to PCB background levels as described by Shirai and Kessel 315 
(1996). Researchers who have continuously monitored PeCDF in a group of Yusho patients, 316 
poisoned by PCB contaminated rice bran oil, have recently reported that these patients maintain 317 
a high level resulting in an infinite half-life (Matsumoto et al 2009). The authors suggested that a 318 
more complicated model to explain excretion in humans were needed.  319 
 320 
One of the strengths of this study was that PCB measurements were available at up to four time 321 
points per participant, and a linear spline model with a single knot was used to estimate PCB 322 
half-lives.  Advantages of the linear spline model with a single knot include generalizability to 323 
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any number of repeated measures, the ability to handle varying numbers of repeated measures 324 
per participant, and the ability to adjust the half-life estimate for covariates such as gender by 325 
adding the appropriate terms and interactions to the model.  326 
 327 
Unlike all previous half-life estimates reported in the scientific literature, ours is based on serum 328 
draws from four time points, which allowed us to explore more than one linear regression PCB 329 
elimination rate.  A single linear regression using all four time points did not achieve as good a 330 
fit as did the linear spline model with a single knot. We did not try more than a single knot as 331 
based on the data; the linear slope for decline appeared much steeper between the first 2 332 
occasions than the latter two.  This bi-phasic decay was also observed by Brown and Lawton 333 
(2001) who tried to fit a pseudo-first order elimination to their studies’ three serum draws.  Other 334 
studies (Phillips et al., 1989; Taylor and Lawrence, 1992; Brown et al., 1989; Wolff et al., 1992) 335 
estimated half-lives based on serum draws at only two time points, which resulted in shorter half-336 
lives (Table 1).  The half-life estimates using the linear spline model with a single knot were 337 
somewhat shorter for Equation A and longer for Equation B than estimates previously published, 338 
because it incorporates high initial PCB body burden (Equation A) and low body burden 339 
(Equation B).  The equation A estimated half-life of 1.8 years for Aroclor 1242 was 31% shorter 340 
than the 2.6-year estimate by Phillips (1989), 81% shorter than the 9.6-year estimate by Seegal et 341 
al. (2011), but the same as the estimate by Taylor et al. (1992).  Equation B estimated an half-life 342 
of 21.8 years for Aroclor 1242, 2.3, 7.4, and 11.1 times longer than the estimates by Seegal et al. 343 
(2011), Phillips (1989), and Taylor et al. (1992), respectively.  Likewise, Equation A estimated a 344 
half-life of 6.01 years for Aroclor 1254, which was 42 and 106%  longer than the estimates by 345 
Phillips (1989) and Taylor et al. (1992), respectively; and 90 and 62% shorter than the estimates 346 
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by Wolff et al (1992) and Seegal et al (2011).  Equation B estimated half-life of 133.33 years for 347 
Aroclor 1254 was 27, 40, 1, and 7.5 times longer than estimates by Phillips (1989), Taylor et al. 348 
(1992), Wolff et al. (1992), and Seegal et al. (2011), respectively.  The half-life estimates using 349 
the linear spline model with a single knot were consistent with elimination rates computed by 350 
Phillips et al., 1989; Taylor and Lawrence, 1992; Brown et al., 1989 for the fast elimination rate 351 
(Equation A) for a high internal dose, and by Wolff et al 1992, Shirai and Kissel 1996, and 352 
Seegal et al. 2011 for the slow elimination rates (Equation B) for a low internal dose approaching 353 
background PCB levels.  354 
 355 
Major limitations of this study include not being able to estimate PCB congener-specific half-356 
lives because congener-specific serum data were not available.  The PCB half-life estimates 357 
would have improved if we could have adjusted for body mass index and age that are known to 358 
affect PCBs half-lives.  Strengths of these half-life estimates include a relatively long 13-year 359 
sampling period, a large study population (191 participants), one to four serum draws per 360 
participants, and three sampling points after occupational exposure ended.  In addition, these 361 
half-life estimates are for individuals with high initial body burdens, which we show here result 362 
in concentration-dependent PCB half-lives. Attempts to back-calculate body burden in highly 363 
exposed workers based on assumption of uniform half-lives will greatly underestimate dose and 364 
overestimate potency as shown for TCDD (Aylward et al 2005).    365 
 366 
6.0 Conclusion 367 
Our PCB half-life estimates using the linear spline model with a single knot take into account 368 
high initial body burden, ongoing environmental exposure, low serum levels, and congeners with 369 
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very long half-lives.  The estimated half-lives during a period of high internal dose were 1.74 370 
years for Aroclor 1242 and 6.01 years for Aroclor 1254, modeling elimination using sera from 371 
the first two serum draws.  Half-lives during a period of low internal dose were estimated to be 372 
21.83 years and 133.33 years for Aroclor 1242 and Aroclor 1254, respectively, using the final 373 
two serum draws.  The transition point for Aroclor 1242 was 138.57 ppb and for Aroclor 1254 374 
was 34.78 ppb. The high internal dose estimates are in general agreement with the half-life 375 
estimates reported in Phillips et al. (1989) and Brown and Lawton (2001), and the low dose 376 
estimates are in agreement with Wolff et al. 1992 and Seegal et al. 2011.  These half-life 377 
estimates may aid in assessing PCB exposures retrospectively and reconstructing PCB dose 378 
estimates for persons on whom biological monitoring was performed only once, which may in 379 
turn help in understanding the toxicological and epidemiological impact of exposure to PCBs in 380 
humans. 381 
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